About us

shutterstock_1547499926 1 (1)

Our vision

Our vision is to offer better protection to patients during acute, severe and life-threatening medical conditions by an effective, user-friendly, safe and immediately active powder-based Intranasal specialized products.

Board of directors

udi gilboa

Udi Gilboa

Co-Founder & Executive Chairman
1_l

Dr. Dalia Megiddo - CEO

Co-founder & Board Member
ronnie-a-hershman-square 1

Dr. Ronnie Hershman

Board Member

Team members

galia

Galia Temtsin Kryaz, Ph.D.

Director of Product Development
Tair

Tair Lapidot, Ph.D

VP R&D and Clinical Development
Carolina

Carolina Abrutzky

VP CMC
Oren

Oren Elmaliah

Director of Finance
irisleader-image

Iris Erez

Commercial & Marketing Director
pic (1)

MIQUEL MARTI JUVANTENY

Director of Business Development
ayeletleader-image

Ayelet Rahav

Senior Director of RA & QA

Advisory Board

yuval tal photo

Prof Yuval Tal

5 : 7 Hochformat

Prof Regina Scherließ

IMG_1592

David M. Fleischer, MD

Our story

main-banner-web 1

Nasus pharma brings the new frontier in Intranasal drug delivery. Late-Stage Specialty Pharma company, offers Powder-Based Intranasal (PBI) specialized product portfolio, to address acute medical conditions and public health threats.